Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic Seizures

Neurology: Neuroimmunology and NeuroInflammation

Volumn 2, Issue 6, 2015, Pages

  Flanagan, Eoin P ^a   Kotsenas, Amy L ^a   Britton, Jeffrey W ^a   McKeon, Andrew ^a   Watson, Robert E ^a   Klein, Christopher J ^a   Boeve, Bradley F ^a   Lowe, Val ^a   Ahlskog, J Eric ^a   Shin, Cheolsu ^a   Boes, Christopher J ^a   Crum, Brian A ^a   Laughlin, Ruple S ^a   Pittock, Sean J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; AUTOANTIBODY; LEUCINE RICH GLIOMA INACTIVATED 1 AUTOANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BASAL GANGLION; BIBLIOGRAPHIC DATABASE; BRAIN DISEASE; CASE STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; DYSTONIC DISORDER; ELECTROENCEPHALOGRAPHY; FACIOBRACHIAL DYSTONIC SEIZURE; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; NEUROIMAGING; NEURORADIOLOGIST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; SEROLOGY;

EID: 84952881492     PISSN: 23327812     EISSN: None     Source Type: Journal    
DOI: 10.1212/NXI.0000000000000161     Document Type: Article

References (25)

1. Irani SR, Buckley C, Vincent A, et al. Immunotherapyresponsive seizure-like episodes with potassium channel antibodies. Neurology 2008;71:1647-1648.
2. Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011;69:892-900.
3. Irani SR, Stagg CJ, Schott JM, et al. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain 2013;136: 3151-3162.
4. Quek AM, Britton JW, McKeon A, et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol 2012;69:582-593.
5. Klein CJ, Lennon VA, Aston PA, et al. Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol 2013;70:229-234.
6. Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 2008;70:1883-1890.
7. Kotsenas AL, Watson RE, Pittock SJ, et al. MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis. AJNR Am J Neuroradiol 2014;35:84-89.
8. Toledano M, Britton JW, McKeon A, et al. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology 2014;82:1578-1586.
9. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010;133:2734-2748.
10. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010;9:776-785.
11. Kokmen E, Naessens JM, Offord KP. A short test of mental status: description and preliminary results. Mayo Clin Proc 1987;62:281-288.
12. Andrade DM, Tai P, Dalmau J, Wennberg R. Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis? Neurology 2011;76:1355-1357.
13. Chabrol E, Navarro V, Provenzano G, et al. Electroclinical characterization of epileptic seizures in leucine-rich, gliomainactivated 1-deficient mice. Brain 2010;133:2749-2762.
14. Devinsky O, Sato S, Kufta CV, et al. Electroencephalographic studies of simple partial seizures with subdural electrode recordings. Neurology 1989;39:527-533.
15. Aradillas E, Schwartzman RJ. Kinesigenic dyskinesia in a case of voltage-gated potassium channel-complex protein antibody encephalitis. Arch Neurol 2011;68:529-532.
16. Striano P. Faciobrachial dystonic attacks: seizures or movement disorder? Ann Neurol 2011;70:179-180; author reply 180.
17. Duncan M, Cholfin J, Restrepo L. Clinical reasoning: a 72-year-old man with rapid cognitive decline and unilateral muscle jerks. Neurology 2014;82:e194-e197.
18. Yoo JY, Hirsch LJ. Limbic encephalitis associated with anti-voltage-gated potassium channel complex antibodies mimicking Creutzfeldt-Jakob disease. JAMA Neurol 2014; 71:79-82.
19. Boesebeck F, Schwarz O, Dohmen B, et al. Faciobrachial dystonic seizures arise from cortico-subcortical abnormal brain areas. J Neurol 2013;260:1684-1686.
20. Jaychandran R, Patel MJ, Netravathi M, Saini J, Satishchandra P, Pal PK. Unusual clinical and imaging characteristics in a patient with voltage-gated potassium channel antibody-associated encephalitis. Neurol India 2012;60:533-534.
21. Plantone D, Renna R, Grossi D, Plantone F, Iorio R. Teaching NeuroImages: Basal ganglia involvement in facio-brachial dystonic seizures associated with LGI1 antibodies. Neurology 2013;80:e183-e184.
22. Ginat DT, Meyers SP. Intracranial lesions with high signal intensity on T1-weighted MR images: differential diagnosis. Radiographics 2012;32:499-516.
23. Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 2014;270:834-841.
24. Fujioka M, Taoka T, Hiramatsu KI, Sakaguchi S, Sakaki T. Delayed ischemic hyperintensity on T1-weighted MRI in the caudoputamen and cerebral cortex of humans after spectacular shrinking deficit. Stroke 1999;30:1038-1042.
25. Bien CG, Vincent A, Barnett MH, et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 2012;135:1622-1638.